HUP0000679A2 - Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders - Google Patents

Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders

Info

Publication number
HUP0000679A2
HUP0000679A2 HU0000679A HUP0000679A HUP0000679A2 HU P0000679 A2 HUP0000679 A2 HU P0000679A2 HU 0000679 A HU0000679 A HU 0000679A HU P0000679 A HUP0000679 A HU P0000679A HU P0000679 A2 HUP0000679 A2 HU P0000679A2
Authority
HU
Hungary
Prior art keywords
treatment
tetrahydro
manufacture
pharmaceutical composition
sleep disorders
Prior art date
Application number
HU0000679A
Other languages
Hungarian (hu)
Inventor
Anders Fink-Jensen
Christian Foged
Original Assignee
Cenes Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cenes Ltd. filed Critical Cenes Ltd.
Priority claimed from PCT/DK1998/000088 external-priority patent/WO1998040072A1/en
Publication of HUP0000679A2 publication Critical patent/HUP0000679A2/en
Publication of HUP0000679A3 publication Critical patent/HUP0000679A3/en

Links

Abstract

The use of 5-phenyl-8-nitro-2,3,4,5-tetrahydro-1H-3-benzazepine derivatives of formula (I) or their salts is claimed for the manufacture of a pharmaceutical composition for the treatment or prevention of sleep disorders and/or sleep disturbances. R3 = H, 1-4C alkyl or 3-7C cycloalkyl; R4 = H; R7 = OH or 1-4C alkoxy; R10 - R12 = H, CF3, halogen or 1-4C alkyl; or R4 + R10 = -CH2CH2-, -CH=CH-, -O-CH2- or -S-CH2, the last two being linked by the heteroatom to the benzene ring; or R10+R11 or R11+R12 = -OCH2CH2-, -OCH2CH2CH2-, -OCH=CH-, -CH2CH2CH2-, -CH2CH=CH- or -CH2CH2CH2CH2-; R13 = halogen or 1-4C alkyl. A corresponding treatment/prevention method is also claimed.
HU0000679A 1997-03-24 1998-03-11 Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders HUP0000679A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4150997P 1997-03-24 1997-03-24
PCT/DK1998/000088 WO1998040072A1 (en) 1997-03-12 1998-03-11 Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders

Publications (2)

Publication Number Publication Date
HUP0000679A2 true HUP0000679A2 (en) 2000-09-28
HUP0000679A3 HUP0000679A3 (en) 2000-10-30

Family

ID=21916894

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000679A HUP0000679A3 (en) 1997-03-24 1998-03-11 Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders

Country Status (1)

Country Link
HU (1) HUP0000679A3 (en)

Also Published As

Publication number Publication date
HUP0000679A3 (en) 2000-10-30

Similar Documents

Publication Publication Date Title
GR3024074T3 (en) Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar).
ES2012527A6 (en) Pharmaceutically useful benzo((beta))pyranes and pyranopyridines
NZ334976A (en) Benzonaphthyridine derivatives and their use for treating airway disorders and dermatoses
DE69227088D1 (en) Use of 1- (aminoalkyl) -3-quinoxalin-2-one derivatives for the production of neuroprotective agents
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
BG103207A (en) Esters of the arylcycloalkanecarboxylic acids, their application, pharmaceutical compositions and their preparation
ES2108595A1 (en) 3(2H)-pyridazinone derivatives and process for the preparation thereof
FI955837A (en) Process for the preparation of an orally administrable solid dosage form containing diclofenac
NO973342L (en) Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative diseases
UA66888C2 (en) 3-tetrahydropyridine-4-yl indoles, a method for the preparation thereof and method for the treatment of mental disorders
HUP0000679A2 (en) Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
SE9702716D0 (en) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
NO973340L (en) Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical composition for the treatment or prophylaxis of obesity
ZA951963B (en) N-benzoylmethyl-piperidines
NO994343L (en) Use of 2,3,4,5 - tetrahydro-1H-3-benzazepines for the preparation of a pharmaceutical composition for the treatment of sleep disorders
AU2287499A (en) Azetidinecarboxamide derivatives for treating cns disorders
IL108290A0 (en) Pyrrolidine derivatives, their preparation and medicaments containing them
AU2178099A (en) Azetidinecarboxamide derivatives for treating cns disorders
MX9703712A (en) 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, process for producing the same, and medicinal composition containing the same.
TW427978B (en) Tetrahydroisoquinoline derivatives
PH30180A (en) Leustroducsin h its preparation and its therapeutic use
MY104630A (en) 4(1h) ouinoline derivatives
MX9705144A (en) Use of carbostyril compounds for inhibition of tnf-alpha.
MX9705379A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis.

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: ADDEX PHARMA SA, CH

Free format text: FORMER OWNER(S): ADDEX PHARMACEUTICALS, SA., CH; CENES LTD., GB

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished